Literature DB >> 25764917

SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme.

Miklós Békés1, Wioletta Rut2, Paulina Kasperkiewicz2, Monique P C Mulder3, Huib Ovaa3, Marcin Drag2, Christopher D Lima4, Tony T Huang1.   

Abstract

Ubiquitin (Ub) and the Ub-like (Ubl) modifier interferon-stimulated gene 15 (ISG15) participate in the host defence of viral infections. Viruses, including the severe acute respiratory syndrome human coronavirus (SARS hCoV), have co-opted Ub-ISG15 conjugation pathways for their own advantage or have evolved effector proteins to counter pro-inflammatory properties of Ub-ISG15-conjugated host proteins. In the present study, we compare substrate specificities of the papain-like protease (PLpro) from the recently emerged Middle East respiratory syndrome (MERS) hCoV to the related protease from SARS, SARS PLpro. Through biochemical assays, we show that, similar to SARS PLpro, MERS PLpro is both a deubiquitinating (DUB) and a deISGylating enzyme. Further analysis of the intrinsic DUB activity of these viral proteases revealed unique differences between the recognition and cleavage specificities of polyUb chains. First, MERS PLpro shows broad linkage specificity for the cleavage of polyUb chains, whereas SARS PLpro prefers to cleave Lys48-linked polyUb chains. Secondly, MERS PLpro cleaves polyUb chains in a 'mono-distributive' manner (one Ub at a time) and SARS PLpro prefers to cleave Lys48-linked polyUb chains by sensing a di-Ub moiety as a minimal recognition element using a 'di-distributive' cleavage mechanism. The di-distributive cleavage mechanism for SARS PLpro appears to be uncommon among USP (Ub-specific protease)-family DUBs, as related USP family members from humans do not display such a mechanism. We propose that these intrinsic enzymatic differences between SARS and MERS PLpro will help to identify pro-inflammatory substrates of these viral DUBs and can guide in the design of therapeutics to combat infection by coronaviruses.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25764917      PMCID: PMC4447217          DOI: 10.1042/BJ20141170

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome.

Authors:  F Almazán; J M González; Z Pénzes; A Izeta; E Calvo; J Plana-Durán; L Enjuanes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 2.  Mechanisms underlying ubiquitination.

Authors:  C M Pickart
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

3.  Introduction to intracellular protein degradation.

Authors:  Mark Hochstrasser
Journal:  Chem Rev       Date:  2009-04       Impact factor: 60.622

4.  A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication.

Authors:  Kiira Ratia; Scott Pegan; Jun Takayama; Katrina Sleeman; Melissa Coughlin; Surendranath Baliji; Rima Chaudhuri; Wentao Fu; Bellur S Prabhakar; Michael E Johnson; Susan C Baker; Arun K Ghosh; Andrew D Mesecar
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-13       Impact factor: 11.205

Review 5.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

6.  Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus.

Authors:  Yahira M Báez-Santos; Anna M Mielech; Xufang Deng; Susan Baker; Andrew D Mesecar
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

7.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

8.  Positional-scanning fluorigenic substrate libraries reveal unexpected specificity determinants of DUBs (deubiquitinating enzymes).

Authors:  Marcin Drag; Jowita Mikolajczyk; Miklos Bekes; Francisca E Reyes-Turcu; Jonathan A Ellman; Keith D Wilkinson; Guy S Salvesen
Journal:  Biochem J       Date:  2008-11-01       Impact factor: 3.857

Review 9.  The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.

Authors:  Yahira M Báez-Santos; Sarah E St John; Andrew D Mesecar
Journal:  Antiviral Res       Date:  2014-12-29       Impact factor: 5.970

Review 10.  Nidovirus papain-like proteases: multifunctional enzymes with protease, deubiquitinating and deISGylating activities.

Authors:  Anna M Mielech; Yafang Chen; Andrew D Mesecar; Susan C Baker
Journal:  Virus Res       Date:  2014-02-07       Impact factor: 3.303

View more
  28 in total

1.  Structural and Biochemical Characterization of Porcine Epidemic Diarrhea Virus Papain-Like Protease 2.

Authors:  Hsu-Feng Chu; Shu-Chun Cheng; Chiao-Yin Sun; Chi-Yuan Chou; Ta-Hsien Lin; Wei-Yi Chen
Journal:  J Virol       Date:  2021-10-13       Impact factor: 6.549

2.  High-throughput matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry-based deubiquitylating enzyme assay for drug discovery.

Authors:  Virginia De Cesare; Jennifer Moran; Ryan Traynor; Axel Knebel; Maria Stella Ritorto; Matthias Trost; Hilary McLauchlan; C James Hastie; Paul Davies
Journal:  Nat Protoc       Date:  2020-11-02       Impact factor: 13.491

3.  X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility for structure-based drug design.

Authors:  Jozlyn R Clasman; Yahira M Báez-Santos; Robert C Mettelman; Amornrat O'Brien; Susan C Baker; Andrew D Mesecar
Journal:  Sci Rep       Date:  2017-01-12       Impact factor: 4.379

4.  Recognition of Lys48-Linked Di-ubiquitin and Deubiquitinating Activities of the SARS Coronavirus Papain-like Protease.

Authors:  Miklós Békés; Gerbrand J van der Heden van Noort; Reggy Ekkebus; Huib Ovaa; Tony T Huang; Christopher D Lima
Journal:  Mol Cell       Date:  2016-05-19       Impact factor: 17.970

5.  Non-hydrolyzable Diubiquitin Probes Reveal Linkage-Specific Reactivity of Deubiquitylating Enzymes Mediated by S2 Pockets.

Authors:  Dennis Flierman; Gerbrand J van der Heden van Noort; Reggy Ekkebus; Paul P Geurink; Tycho E T Mevissen; Manuela K Hospenthal; David Komander; Huib Ovaa
Journal:  Cell Chem Biol       Date:  2016-04-07       Impact factor: 8.116

6.  MINDY-1 Is a Member of an Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating Enzymes.

Authors:  Syed Arif Abdul Rehman; Yosua Adi Kristariyanto; Soo-Youn Choi; Pedro Junior Nkosi; Simone Weidlich; Karim Labib; Kay Hofmann; Yogesh Kulathu
Journal:  Mol Cell       Date:  2016-06-09       Impact factor: 17.970

7.  Cyanobacterial metabolites as promising drug leads against the Mpro and PLpro of SARS-CoV-2: an in silico analysis.

Authors:  Devashan Naidoo; Ayan Roy; Pallab Kar; Taurai Mutanda; Akash Anandraj
Journal:  J Biomol Struct Dyn       Date:  2020-07-21

8.  Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes.

Authors:  Wioletta Rut; Mikolaj Zmudzinski; Scott J Snipas; Miklos Bekes; Tony T Huang; Marcin Drag
Journal:  Chem Sci       Date:  2020-05-27       Impact factor: 9.825

9.  Crystal structure of SARS-CoV-2 papain-like protease.

Authors:  Xiaopan Gao; Bo Qin; Pu Chen; Kaixiang Zhu; Pengjiao Hou; Justyna Aleksandra Wojdyla; Meitian Wang; Sheng Cui
Journal:  Acta Pharm Sin B       Date:  2020-09-02       Impact factor: 11.413

10.  Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies.

Authors:  Lee A Armstrong; Sven M Lange; Virginia Dee Cesare; Stephen P Matthews; Raja Sekhar Nirujogi; Isobel Cole; Anthony Hope; Fraser Cunningham; Rachel Toth; Rukmini Mukherjee; Denisa Bojkova; Franz Gruber; David Gray; Paul G Wyatt; Jindrich Cinatl; Ivan Dikic; Paul Davies; Yogesh Kulathu
Journal:  PLoS One       Date:  2021-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.